Kahn, C. Ronald
Harvard Medical School,
United States
2023 Rank: 584
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Endocrinology & Metabolism
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 28 out of 87976 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 584 | 631 |
| Total Cites | 90016 | 98119 |
| H-index | 152 | 160 |
| Hm-index | 58 | 61 |
| Number of Single Authored Papers | 28 | 28 |
| Total Cites to Single Authored Papers | 1611 | 1659 |
| Number of Single+First Authored Papers | 78 | 78 |
| Total Cites to Single+First Authored Papers | 3398 | 3523 |
| Number of Single+First+Last Authored Papers | 510 | 510 |
| Total Cites to Single+First+Last Authored Papers | 57528 | 61716 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 62838 | 65457 |
| Ratio of Total Citations to Distinct Citing Papers | 1.43 | 1.50 |
| Self-Citation Percentage |
8.26%
|
|
Kahn, C. Ronald
Harvard Medical School,
United States
2022 Rank: 562
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Endocrinology & Metabolism
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 28 out of 84176 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 562 | 605 |
| Total Cites | 83300 | 91021 |
| H-index | 148 | 155 |
| Hm-index | 56 | 59 |
| Number of Single Authored Papers | 28 | 28 |
| Total Cites to Single Authored Papers | 1559 | 1607 |
| Number of Single+First Authored Papers | 78 | 78 |
| Total Cites to Single+First Authored Papers | 3159 | 3280 |
| Number of Single+First+Last Authored Papers | 501 | 501 |
| Total Cites to Single+First+Last Authored Papers | 53341 | 57338 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 57906 | 60404 |
| Ratio of Total Citations to Distinct Citing Papers | 1.44 | 1.51 |
| Self-Citation Percentage |
8.48%
|
|
Kahn, C. Ronald
Harvard Medical School,
United States
2021 Rank: 557
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Endocrinology & Metabolism
SubField 2:
Biochemistry & Molecular Biology
Rank in SubField 1: 27 out of 81805 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 557 | 589 |
| Total Cites | 80277 | 87740 |
| H-index | 145 | 153 |
| Hm-index | 55 | 58 |
| Number of Single Authored Papers | 27 | 27 |
| Total Cites to Single Authored Papers | 1523 | 1571 |
| Number of Single+First Authored Papers | 77 | 77 |
| Total Cites to Single+First Authored Papers | 3044 | 3156 |
| Number of Single+First+Last Authored Papers | 494 | 494 |
| Total Cites to Single+First+Last Authored Papers | 51459 | 55308 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 55648 | 58095 |
| Ratio of Total Citations to Distinct Citing Papers | 1.44 | 1.51 |
| Self-Citation Percentage |
8.51%
|
|
Kahn, C. Ronald
Joslin Diabetes Center,
United States
2020 Rank: 531
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Endocrinology & Metabolism
SubField 2:
Developmental Biology
Rank in SubField 1: 25 out of 69094 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 531 | 554 |
| Total Cites | 74366 | 81543 |
| H-index | 140 | 151 |
| Hm-index | 54 | 56 |
| Number of Single Authored Papers | 27 | 27 |
| Total Cites to Single Authored Papers | 1488 | 1536 |
| Number of Single+First Authored Papers | 78 | 78 |
| Total Cites to Single+First Authored Papers | 2929 | 3041 |
| Number of Single+First+Last Authored Papers | 492 | 492 |
| Total Cites to Single+First+Last Authored Papers | 47326 | 51023 |
| Composite Score | 4 | 4 |
| Number of Distinct Citing Papers | 51043 | 53364 |
| Ratio of Total Citations to Distinct Citing Papers | 1.46 | 1.53 |
| Self-Citation Percentage |
8.80%
|
|